Business Description
ImmunoPrecise Antibodies Ltd
NAICS : 325412
SIC : 3741
ISIN : CA45257F1018
Description
ImmunoPrecise Antibodies Ltd is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series proprietary and patented technologies. The company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.22 | |||||
| Equity-to-Asset | 0.55 | |||||
| Debt-to-Equity | 0.5 | |||||
| Debt-to-EBITDA | -0.67 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -3.33 | |||||
| Beneish M-Score | -3.07 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -7 | |||||
| 3-Year EBITDA Growth Rate | -111.7 | |||||
| 3-Year EPS without NRI Growth Rate | -5.6 | |||||
| 3-Year FCF Growth Rate | -18 | |||||
| 3-Year Book Growth Rate | -27.1 | |||||
| Future 3-5Y Total Revenue Growth Rate | 12.32 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.68 | |||||
| 9-Day RSI | 48.92 | |||||
| 14-Day RSI | 47.19 | |||||
| 6-1 Month Momentum % | -62.04 | |||||
| 12-1 Month Momentum % | -72.15 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.01 | |||||
| Quick Ratio | 0.85 | |||||
| Cash Ratio | 0.28 | |||||
| Days Inventory | 67.05 | |||||
| Days Sales Outstanding | 51.68 | |||||
| Days Payable | 142.99 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -12 | |||||
| Shareholder Yield % | -47.24 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 50.26 | |||||
| Operating Margin % | -59.39 | |||||
| Net Margin % | -114.22 | |||||
| FCF Margin % | -37.41 | |||||
| ROE % | -68.3 | |||||
| ROA % | -41.23 | |||||
| ROIC % | -22.35 | |||||
| ROC (Joel Greenblatt) % | -182.32 | |||||
| ROCE % | -52.49 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.61 | |||||
| PB Ratio | 0.51 | |||||
| Price-to-Tangible-Book | 9.98 | |||||
| EV-to-EBIT | -0.98 | |||||
| EV-to-EBITDA | -1.21 | |||||
| EV-to-Revenue | 1.21 | |||||
| EV-to-Forward-Revenue | 1.21 | |||||
| EV-to-FCF | -3.25 | |||||
| Earnings Yield (Greenblatt) % | -102.04 | |||||
| FCF Yield % | -53.26 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:IPA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ImmunoPrecise Antibodies Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 17.649 | ||
| EPS (TTM) ($) | -0.768 | ||
| Beta | 0 | ||
| Volatility % | 39.03 | ||
| 14-Day RSI | 47.19 | ||
| 14-Day ATR ($) | 0.046602 | ||
| 20-Day SMA ($) | 0.397929 | ||
| 12-1 Month Momentum % | -72.15 | ||
| 52-Week Range ($) | 0.3248 - 2.6 | ||
| Shares Outstanding (Mil) | 31.06 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ImmunoPrecise Antibodies Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ImmunoPrecise Antibodies Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
ImmunoPrecise Antibodies Ltd Frequently Asked Questions
What is ImmunoPrecise Antibodies Ltd(IPA)'s stock price today?
The current price of IPA is $0.41. The 52 week high of IPA is $2.60 and 52 week low is $0.32.
When is next earnings date of ImmunoPrecise Antibodies Ltd(IPA)?
The next earnings date of ImmunoPrecise Antibodies Ltd(IPA) is 2025-03-14 Est..
Does ImmunoPrecise Antibodies Ltd(IPA) pay dividends? If so, how much?
ImmunoPrecise Antibodies Ltd(IPA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers